These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 386428)

  • 1. Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat.
    Sun FF; Taylor BM; Sutter DM; Weeks JR
    Prostaglandins; 1979 May; 17(5):753-9. PubMed ID: 386428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Weimer KE; Frölich JC
    J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished urinary prostacyclin metabolite in essential hypertension.
    Grose JH; Lebel M; Gbeassor FM
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():121s-123s. PubMed ID: 7004719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.
    Taylor BM; Sun FF
    J Pharmacol Exp Ther; 1980 Jul; 214(1):24-30. PubMed ID: 6993658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite.
    Dembélé-Duchesne MJ; Thaler-Dao H; Chavis C; Crastes de Paulet A
    Prostaglandins; 1982 Nov; 24(5):701-14. PubMed ID: 6298904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY; Lee WH; Quilley CP; McGiff JC
    Fed Proc; 1981 May; 40(7):2001-4. PubMed ID: 7014260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous.
    Sun FF; Taylor BM; Lincoln FH; Sebek OK
    Prostaglandins; 1980 Oct; 20(4):729-33. PubMed ID: 6258195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NADP-linked prostacyclin dehydrogenase in rabbit kidney.
    Korff JM; Jarabak J
    Prostaglandins; 1981 May; 21(5):719-25. PubMed ID: 7041194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
    Diz DI; Baer PG; Nasjletti A
    J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for 6-keto-PGF1 alpha in adrenal cortex of the rat and effects of 6-keto-PGF1 alpha and PGI2 on adrenal cAMP levels and steroidogenesis.
    Laychock SG; Walker L
    Prostaglandins; 1979 Nov; 18(5):793-811. PubMed ID: 232283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of prostacyclin in Cynomolgus monkey.
    Sun FF; Taylor BM
    Prostaglandins; 1981 Feb; 21(2):307-14. PubMed ID: 7012936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of prostacyclin in blood vessels.
    Wong PY; Sun FF; McGiff JC
    J Biol Chem; 1978 Aug; 253(16):5555-7. PubMed ID: 27516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase products and cyclic nucleotide levels with infusion of arachidonic acid, PGI2, PGE2, PGF2, and 6-keto-PGF1 in an isolated dog lung.
    Littner M; Kazmi G; Lott F; Golub M; Berger M
    Am Rev Respir Dis; 1983 Nov; 128(5):868-74. PubMed ID: 6314861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
    J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney.
    Rosenkranz B; Hofbauer K; Fischer C; Frölich JC
    Ren Physiol; 1982; 5(4):186-91. PubMed ID: 6750728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin.
    Balazy M; Brass EP; Gerber JG; Nies AS
    Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation.
    Noris M; Benigni A; Siegler R; Gaspari F; Casiraghi F; Mancini ML; Remuzzi G
    Am J Kidney Dis; 1992 Aug; 20(2):144-9. PubMed ID: 1496967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the prostacyclin products, 6-keto prostaglandin E1 and 6-keto prostaglandin F1 alpha, on bone resorption in vitro.
    Neuman SD; Raisz LG
    Prostaglandins Leukot Med; 1984 Jul; 15(1):103-8. PubMed ID: 6382342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.